Kits Eyecare (TSE:KITS) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
KITS Eyecare Ltd. announced a significant growth in its second quarter of 2024, with a 26% increase in revenue to $37.9 million and a notable rise in Canadian revenue by 47%. The company also marked its seventh consecutive quarter with positive adjusted EBITDA, highlighting operational efficiency and a strong financial performance.
For further insights into TSE:KITS stock, check out TipRanks’ Stock Analysis page.